United States

Biocept Inc (BIOC)

Track

Ticker: BIOC Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 9 Dec 2021
Value US$1,640,871.71 | Price 215.58 | Shares 98,623 (+27.3%)
Sale 9 Dec 2021
Value US$1,561,561.49 | Price 222.60 | Shares 10,752 (+28.1%)
Sale 9 Dec 2021
Value US$1,473.85 | Price 4.06 | Shares 363 (-10.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-10 2021-12-09 S Sale
1.4
HALE DAVID F
Non-Executive Director
98,623 +27.3%
215.58
US$1,640,872 		98,623 +27.3% 215.58 US$1,640,872
2021-12-10 2021-12-09 S Sale
1.4
HALE DAVID F
Non-Executive Director
10,752 +28.1%
222.60
US$1,561,561 		10,752 +28.1% 222.60 US$1,561,561
2021-12-10 2021-12-09 S Sale
1.4
HALE DAVID F
Non-Executive Director
97,429 +13.5%
450.73
US$4,473,679 		97,429 +13.5% 450.73 US$4,473,679
2020-06-12 2020-06-12 S Sale
1.4
HALE DAVID F
Non-Executive Director
556 -39.1%
0.56
US$309 		556 -39.1% 0.56 US$309
2020-06-12 2020-06-12 S Sale
1.4
HALE DAVID F
Non-Executive Director
445 -79.9%
0.55
US$247 		445 -79.9% 0.55 US$247
2020-06-12 2020-06-12 S Sale
1.4
HALE DAVID F
Non-Executive Director
159 -4.4%
0.56
US$89 		159 -4.4% 0.56 US$89
2018-06-06 2018-01-30 B Purchase Gerhardt Bruce
25,000
0.00
US$0 		25,000 0.00 US$0
2016-10-21 2016-10-19 B Purchase Nall Michael W.

CEO & President

Executive Director
36,363 +275.2%
1.10
US$39,999 		36,363 +275.2% 1.10 US$39,999
2016-10-21 2016-10-19 B Purchase Chandler Marsha Alpert Non-Executive Director
4,545 +681.4%
1.10
US$5,000 		4,545 +681.4% 1.10 US$5,000
2016-10-21 2016-10-19 B Purchase HALE DAVID F Non-Executive Director
90,909 +499.8%
1.10
US$100,000 		90,909 +499.8% 1.10 US$100,000
2016-10-21 2016-10-19 B Purchase Neff Edward A. Non-Executive Director
227,272 +363.9%
1.10
US$249,999 		227,272 +363.9% 1.10 US$249,999
2016-10-21 2016-10-19 B Purchase Kennedy Timothy

CFO, Sr V.P. Operations & Sec.

Officer
36,363 +145.5%
1.10
US$39,999 		36,363 +145.5% 1.10 US$39,999
2016-10-21 2016-10-19 B Purchase ARNOLD LYLE J

SR VP of R&D and CSO

Officer
45,000 +222.4%
1.10
US$49,500 		45,000 +222.4% 1.10 US$49,500
2016-10-21 2016-10-19 B Purchase Reiss Claire Large shareholder
227,272 +27.7%
1.10
US$249,999 		227,272 +27.7% 1.10 US$249,999
2016-10-21 2016-10-19 B Purchase Singh Veena

Sr VP & Sr Med Director

Officer
10,000 +60.0%
1.10
US$11,000 		10,000 +60.0% 1.10 US$11,000
2016-10-21 2016-10-19 B Purchase HUEBNER BRUCE A Non-Executive Director
20,000 +500.0%
1.10
US$22,000 		20,000 +500.0% 1.10 US$22,000
2016-10-21 2016-10-19 B Purchase Gerhardt Bruce Non-Executive Director
50,000 +214.6%
1.10
US$55,000 		50,000 +214.6% 1.10 US$55,000
2016-10-21 2016-10-19 B Purchase Wilson Margaret Faye Non-Executive Director
13,636 +119.3%
1.10
US$15,000 		13,636 +119.3% 1.10 US$15,000
2016-05-05 2016-05-04 B Purchase Gerhardt Bruce Non-Executive Director
25,000 +73.6%
1.00
US$25,000 		25,000 +73.6% 1.00 US$25,000
2016-05-05 2016-05-04 B Purchase Reiss Claire Large shareholder
614,273 +33.3%
1.00
US$614,273 		614,273 +33.3% 1.00 US$614,273
2016-05-05 2016-05-04 B Purchase Neff Edward A. Non-Executive Director
100,000 +774.4%
1.00
US$100,000 		100,000 +774.4% 1.00 US$100,000
2016-05-05 2016-05-04 B Purchase HALE DAVID F Non-Executive Director
50,000 +56.6%
1.00
US$50,000 		50,000 +56.6% 1.00 US$50,000
2015-06-02 2015-06-01 B Purchase Singh Veena

Sr VP & Sr Med Director

Officer
3,200 +177.8%
3.10
US$9,920 		3,200 +177.8% 3.10 US$9,920
2015-06-02 2015-05-29 B Purchase Singh Veena

Sr VP & Sr Med Director

Officer
1,800 +inf%
3.05
US$5,490 		1,800 +inf% 3.05 US$5,490
2017-03-29 2015-03-16 B Purchase ROYSTON IVOR Non-Executive Director
5,667 +48.7%
8.76
US$49,643 		5,667 +48.7% 8.76 US$49,643
2015-02-18 2015-02-13 B Purchase HALE DAVID F

Chairman

Executive Director
40,000 +73.3%
1.25
US$50,000 		40,000 +73.3% 1.25 US$50,000
2015-02-18 2015-02-13 B Purchase Wilson Margaret Faye Non-Executive Director
4,000 +78.8%
1.25
US$5,000 		4,000 +78.8% 1.25 US$5,000
2015-02-18 2015-02-13 B Purchase Gerhardt Bruce Non-Executive Director
20,000 +381.0%
1.25
US$25,000 		20,000 +381.0% 1.25 US$25,000
2015-02-18 2015-02-13 B Purchase HUEBNER BRUCE A Non-Executive Director
12,000 +inf%
1.25
US$15,000 		12,000 +inf% 1.25 US$15,000
2015-02-18 2015-02-13 B Purchase ROYSTON IVOR Non-Executive Director
12,000 +247.0%
1.25
US$15,000 		12,000 +247.0% 1.25 US$15,000
2015-02-18 2015-02-13 B Purchase Chandler Marsha Alpert Non-Executive Director
2,000 +39.4%
1.25
US$2,500 		2,000 +39.4% 1.25 US$2,500
2015-02-18 2015-02-13 B Purchase Neff Edward A. Non-Executive Director
40,000 +27.1%
1.25
US$50,000 		40,000 +27.1% 1.25 US$50,000
2015-02-18 2015-02-13 B Purchase Nall Michael W.

CEO & President

Executive Director
12,000 +inf%
1.25
US$15,000 		12,000 +inf% 1.25 US$15,000
Explore more

More insider trading research around Biocept Inc

More insider trades in United States
Insider trading in North America